XML 61 R46.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity - Inducement Plan (Details) - Inducement Plan
1 Months Ended 12 Months Ended
Jan. 31, 2022
shares
Aug. 31, 2021
shares
Jan. 31, 2020
installment
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
shares
Share-based Compensation Arrangement by Share-based Payment Award          
Expiration period     10 years    
Unrecognized compensation expense related to unvested options | $       $ 1,672,270  
Intrinsic value of options exercised | $       1,944,000  
Cash proceeds from exercise of stock options | $       $ 20,790  
Period for unrecognized compensation expense related to unvested options yet has not been recognized       3 years 7 months 6 days  
Increase in number of shares of common stock 3,000,000     2,000,000  
Common stock shares issued       10,092 0
Stock options granted       1,747,600  
Fair value of shares vested | $       $ 73,334  
Options exercised       10,092  
Stock options vesting based on service          
Share-based Compensation Arrangement by Share-based Payment Award          
Vesting percentage   25.00%      
Period remaining underlying shares vest   36 months      
Stock options granted   1,098,400      
Stock options vesting based on performance          
Share-based Compensation Arrangement by Share-based Payment Award          
Stock options granted   549,200      
Maximum fair value of option excluded from the unrecognized compensation expense | $       $ 798,053  
Chief Executive Officer          
Share-based Compensation Arrangement by Share-based Payment Award          
Stock options granted   1,647,600      
Upon first anniversary of start date          
Share-based Compensation Arrangement by Share-based Payment Award          
Vesting percentage     25.00%    
Number of monthly installments | installment     36    
Period from date of termination that any vested options shall expire     90 days    
Vesting upon FDA Approval | Stock options vesting based on performance          
Share-based Compensation Arrangement by Share-based Payment Award          
Vesting percentage   5.00%      
Vesting upon First Commercial Sale | Stock options vesting based on performance          
Share-based Compensation Arrangement by Share-based Payment Award          
Vesting percentage   5.00%      
Common Stock          
Share-based Compensation Arrangement by Share-based Payment Award          
Common stock authorized     500,000